Product news

GlaxoSmithKline announced the approval of Requip XL(ropinirole extended-release tablets) in the US for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The product should be available in pharmacies in mid-July 2008.
You must be a registered member of MMM to post a comment.